Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Find generic entry opportunities
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Flunisolide aerosol formulations|
|Abstract:||Pharmaceutical aerosol formulations comprising flunisolide, ethanol, and a propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane, and a mixture thereof.|
|Inventor(s):||Tzou; Tsi-Zong (Lake Elmo, MN), Schultz; Robert K. (Edina, MN), Ross; Danna L. (Pine Springs, MN)|
|Assignee:||3M Innovative Prperties Company (St. Paul, MN)|
Patent Claim Types:|
see list of patent claims
|Formulation; Compound; Use; Delivery;|
Field: Not categorized
Back Citations: 29th percentile
Forward Citations: 6th percentile
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Australia||1098695||<disabled in preview>|
|Australia||680967||<disabled in preview>|
|Canada||2178473||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.